WO2006116165A1 - Chromane and chromene derivatives and uses thereof - Google Patents
Chromane and chromene derivatives and uses thereof Download PDFInfo
- Publication number
- WO2006116165A1 WO2006116165A1 PCT/US2006/015208 US2006015208W WO2006116165A1 WO 2006116165 A1 WO2006116165 A1 WO 2006116165A1 US 2006015208 W US2006015208 W US 2006015208W WO 2006116165 A1 WO2006116165 A1 WO 2006116165A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- disorder
- mmol
- methyl
- compound
- chromen
- Prior art date
Links
- 0 C*c1ccccc1Cl Chemical compound C*c1ccccc1Cl 0.000 description 15
- QSLIBMPDVLSAKM-UHFFFAOYSA-N CC(C)c(cc1)ccc1[ClH+] Chemical compound CC(C)c(cc1)ccc1[ClH+] QSLIBMPDVLSAKM-UHFFFAOYSA-N 0.000 description 1
- GEWYYMIVTBJEPG-UHFFFAOYSA-N CCc1cccc(F)c1F Chemical compound CCc1cccc(F)c1F GEWYYMIVTBJEPG-UHFFFAOYSA-N 0.000 description 1
- SBHVNORGKIPGCL-UHFFFAOYSA-N Clc(cc1I)ccc1Cl Chemical compound Clc(cc1I)ccc1Cl SBHVNORGKIPGCL-UHFFFAOYSA-N 0.000 description 1
- WTIFQQJONSPUFQ-UHFFFAOYSA-N NCC(CC1)Oc(c(-c2ccccc2O)c2)c1cc2F Chemical compound NCC(CC1)Oc(c(-c2ccccc2O)c2)c1cc2F WTIFQQJONSPUFQ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/20—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 hydrogenated in the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
- C07D313/02—Seven-membered rings
- C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
- C07D313/08—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2007013163A MX2007013163A (es) | 2005-04-22 | 2006-04-21 | Derivados de cromano y cromeno y usos de los mismos. |
BRPI0610027-9A BRPI0610027A2 (pt) | 2005-04-22 | 2006-04-21 | derivados de cromano e cromeno e usos dos mesmos |
JP2008507952A JP2008538576A (ja) | 2005-04-22 | 2006-04-21 | クロマンおよびクロメン誘導体およびその使用 |
EP06758490A EP1874756A1 (en) | 2005-04-22 | 2006-04-21 | Chromane and chromene derivatives and uses thereof |
AU2006239937A AU2006239937A1 (en) | 2005-04-22 | 2006-04-21 | Chromane and chromene derivatives and uses thereof |
CA002605587A CA2605587A1 (en) | 2005-04-22 | 2006-04-21 | Chromane and chromene derivatives and uses thereof |
IL186837A IL186837A0 (en) | 2005-04-22 | 2007-10-22 | Chromane and chromene derivatives and uses thereof |
NO20075641A NO20075641L (no) | 2005-04-22 | 2007-11-06 | Kroman og kromenderivater og ders anvendelse |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US67382005P | 2005-04-22 | 2005-04-22 | |
US60/673,820 | 2005-04-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2006116165A1 true WO2006116165A1 (en) | 2006-11-02 |
Family
ID=36888961
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2006/015208 WO2006116165A1 (en) | 2005-04-22 | 2006-04-21 | Chromane and chromene derivatives and uses thereof |
Country Status (19)
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007123941A2 (en) * | 2006-04-18 | 2007-11-01 | Wyeth | Chromane and chromene derivatives and uses thereof |
WO2007132841A1 (ja) | 2006-05-16 | 2007-11-22 | Takeda Pharmaceutical Company Limited | 縮合複素環化合物およびその用途 |
WO2008052088A1 (en) * | 2006-10-25 | 2008-05-02 | Wyeth | Chromane derivatives, synthesis thereof, and intermediates thereto |
WO2008052087A1 (en) * | 2006-10-24 | 2008-05-02 | Wyeth | Chromane derivatives and uses thereof |
WO2009063992A1 (ja) | 2007-11-15 | 2009-05-22 | Takeda Pharmaceutical Company Limited | 縮合ピリジン誘導体およびその用途 |
WO2011071136A1 (ja) | 2009-12-11 | 2011-06-16 | アステラス製薬株式会社 | 線維筋痛症治療剤 |
US8676322B2 (en) | 2008-01-30 | 2014-03-18 | Boston Scientific Neuromodulation Corporation | Methods and systems of treating pancreatitis pain |
US8914112B2 (en) | 2008-01-23 | 2014-12-16 | Boston Scienctific Neuromodulation Corporation | Methods and systems of treating pancreatitis pain caused by sphincter of Oddi dysfunction |
WO2015066344A1 (en) | 2013-11-01 | 2015-05-07 | Arena Pharmaceuticals, Inc. | 5-ht2c receptor agonists and compositions and methods of use |
CN105392786A (zh) * | 2013-06-21 | 2016-03-09 | 济州大学校产学协力团 | 新型类黄酮及其用途 |
US9334212B2 (en) | 2010-12-21 | 2016-05-10 | Colgate-Palmolive Company | Compounds and compositions |
WO2019131902A1 (ja) | 2017-12-27 | 2019-07-04 | 武田薬品工業株式会社 | 腹圧性尿失禁および便失禁の治療薬 |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0210397D0 (en) | 2002-05-07 | 2002-06-12 | Ferring Bv | Pharmaceutical formulations |
US7435837B2 (en) * | 2003-10-24 | 2008-10-14 | Wyeth | Dihydrobenzofuranyl alkanamine derivatives and methods for using same |
US20050261347A1 (en) * | 2003-10-24 | 2005-11-24 | Wyeth | Dihydrobenzofuranyl alkanamine derivatives and methods for using same |
GT200500296A (es) * | 2004-10-21 | 2006-10-02 | Sintesis asimetrica de derivados del dehidrobenzofurano | |
GT200500297A (es) * | 2004-10-21 | 2006-10-27 | Sintesis asimetrica de dehidrobenzofuranos sustituidos | |
MX2007012883A (es) * | 2005-04-22 | 2007-12-10 | Wyeth Corp | Derivados de dihidrobenzofurano y usos de los mismos. |
EP1871355A1 (en) * | 2005-04-22 | 2008-01-02 | Wyeth | New therapeutic combianations for the treatment or prevention of depression |
EP1871754A1 (en) * | 2005-04-22 | 2008-01-02 | Wyeth a Corporation of the State of Delaware | Dihydrobenzofuran derivatives and uses thereof |
WO2006116151A1 (en) * | 2005-04-22 | 2006-11-02 | Wyeth | Benzofuranyl alkanamine derivatives and uses thereof as 5-ht2c agonists |
CN101203216A (zh) * | 2005-04-22 | 2008-06-18 | 惠氏公司 | 二氢苯并呋喃衍生物及其用途 |
BRPI0610046A2 (pt) * | 2005-04-22 | 2010-05-25 | Wyeth Corp | derivados de benzodioxano e benzodioxolano e usos destes |
BRPI0610028A2 (pt) * | 2005-04-22 | 2010-05-18 | Wyeth Corp | combinações terapêuticas para o tratamento ou a prevenção de distúrbios psicóticos |
JP2008538578A (ja) * | 2005-04-22 | 2008-10-30 | ワイス | 疼痛の治療 |
CA2605587A1 (en) * | 2005-04-22 | 2006-11-02 | Wyeth | Chromane and chromene derivatives and uses thereof |
CN101203217A (zh) * | 2005-04-24 | 2008-06-18 | 惠氏公司 | 调节膀胱功能的方法 |
CL2007000775A1 (es) * | 2006-03-24 | 2008-01-25 | Wyeth Corp | Uso de compuestos derivados de benzofurano para el tratamiento de un desorden cognitivo. |
RU2472539C2 (ru) | 2007-08-06 | 2013-01-20 | Аллерган, Инк. | Способы и устройства для доставки препарата десмопрессина |
EP2116618A1 (en) | 2008-05-09 | 2009-11-11 | Agency for Science, Technology And Research | Diagnosis and treatment of Kawasaki disease |
US11963995B2 (en) | 2008-05-21 | 2024-04-23 | Ferring B.V. | Methods comprising desmopressin |
PT3085381T (pt) | 2008-05-21 | 2018-05-18 | Ferring Bv | Desmopressina orodispersível para aumentar o período inicial de sono não perturbado pela noctúria |
US20100286045A1 (en) | 2008-05-21 | 2010-11-11 | Bjarke Mirner Klein | Methods comprising desmopressin |
CN101921252B (zh) * | 2010-07-02 | 2012-05-09 | 中国科学院上海有机化学研究所 | 1-氧杂苯并杂环类化合物、合成方法和用途 |
CN109970533B (zh) * | 2012-12-18 | 2022-06-14 | 帝斯曼知识产权资产管理有限公司 | 由(r)-6,10,14-三甲基十五碳-5-烯-2-酮制备的(6r,10r)-6,10,14-三甲基十五烷-2-酮 |
CN107531674B (zh) | 2015-02-11 | 2020-07-31 | 赛诺维信制药公司 | 用于治疗cns障碍的1-杂环基异苯并二氢吡喃基化合物和类似物 |
EP3490607A4 (en) | 2016-07-29 | 2020-04-08 | Sunovion Pharmaceuticals Inc. | COMPOUNDS AND COMPOSITIONS, AND USES THEREOF |
CN116514761A (zh) | 2016-07-29 | 2023-08-01 | 赛诺维信制药公司 | 化合物、组合物及其用途 |
SG11202000669VA (en) | 2017-08-02 | 2020-02-27 | Sunovion Pharmaceuticals Inc | Isochroman compounds and uses thereof |
JP2022521208A (ja) * | 2019-02-17 | 2022-04-06 | ニューラウェル セラピューティクス | うつ病及び他の障害の治療のための組成物及び方法 |
KR20210139376A (ko) | 2019-03-14 | 2021-11-22 | 선오비온 파마슈티컬스 인코포레이티드 | 이소크로마닐 화합물의 염, 및 이의 결정성 형태, 제조방법, 치료 용도 및 약제학적 조성물 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003029238A1 (en) * | 2001-10-04 | 2003-04-10 | Wyeth | Chroman derivatives as 5-hydroxytryptamine-6 ligands |
WO2003029239A1 (en) * | 2001-10-04 | 2003-04-10 | Wyeth | Chroman and benzofuran derivatives as 5-hydroxytryptamine-6 ligands |
WO2003031439A1 (en) * | 2001-10-05 | 2003-04-17 | Wyeth | Antidepressant chroman and chromene derivatives of 3-(1,2,3,6-tetrahydro-4-pyridinyl)-1h-indole |
WO2005044812A1 (en) * | 2003-10-24 | 2005-05-19 | Wyeth A Corporation Of The State Of Delaware | Dihydrobenzofuranyl alkanamine derivatives as 5ht2c agonists |
Family Cites Families (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1262078A (en) | 1968-05-24 | 1972-02-02 | Fisons Pharmaceuticals Ltd | Preparation of phenoxy fumaric acid compounds and chromone-2-carboxylic acid compounds therefrom |
US4536518A (en) * | 1979-11-01 | 1985-08-20 | Pfizer Inc. | Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine |
US4654362A (en) * | 1983-12-05 | 1987-03-31 | Janssen Pharmaceutica, N.V. | Derivatives of 2,2'-iminobisethanol |
GB8814057D0 (en) * | 1988-06-14 | 1988-07-20 | Lundbeck & Co As H | New enantiomers & their isolation |
US5089637A (en) * | 1990-03-21 | 1992-02-18 | Pfizer Inc. | Process and intermediates for 2r-benzyl-chroman-6-carbaldehyde |
JP3283114B2 (ja) * | 1992-09-07 | 2002-05-20 | クミアイ化学工業株式会社 | 縮合ヘテロ環誘導体及び農園芸用殺菌剤 |
US5731324A (en) * | 1993-07-22 | 1998-03-24 | Eli Lilly And Company | Glycoprotein IIb/IIIa antagonists |
RU2129556C1 (ru) * | 1993-08-19 | 1999-04-27 | Жансен Фармасетика Н.В. | Производное дигидробензопирана, обладающее сосудосуживающим действием, промежуточные соединения, способы получения, фармацевтическая композиция и способ ее получения |
US6150402A (en) * | 1994-08-15 | 2000-11-21 | Loma Linda University Medical Center | Natriuretic compounds |
DE4430089A1 (de) | 1994-08-25 | 1996-02-29 | Bayer Ag | Verfahren zur enzymatischen Herstellung von enantiomerenreinen Chroman-2-carbonsäuren und deren Derivaten |
PT707007E (pt) * | 1994-10-14 | 2002-06-28 | Merck Patent Gmbh | Derivados amino(tio)eter como agentes activos no snc |
US5658796A (en) * | 1995-06-07 | 1997-08-19 | Seprachem, Inc. | Optical resolution of alkyl chroman-2-carboxylates |
CA2276278C (en) * | 1997-02-27 | 2009-04-07 | Takeda Chemical Industries, Ltd. | Amine compounds, their production and use |
FR2763335B1 (fr) * | 1997-05-16 | 2000-11-24 | Adir | Nouveaux composes heterocycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
US6133277A (en) * | 1997-12-05 | 2000-10-17 | Janssen Pharmaceutica N.V. | (Benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties |
US20060258176A1 (en) * | 1998-02-05 | 2006-11-16 | Asm Japan K.K. | Method for forming insulation film |
US6011035A (en) * | 1998-06-30 | 2000-01-04 | Neuromed Technologies Inc. | Calcium channel blockers |
FR2791675B1 (fr) | 1999-03-30 | 2001-05-04 | Synthelabo | Derives de n-[2-(4-aminophenyl) ethyl] -2,3-dihydro-1,4- benzodioxinne-2-methanamine, leur preparation et leur application en therapeutique |
DE10044091A1 (de) * | 2000-09-07 | 2002-04-04 | Merck Patent Gmbh | Chromanonderivate |
US20040029788A1 (en) * | 2000-11-01 | 2004-02-12 | Hans-Markus Bender | Methods and compositions for the treatment of diseases of the eye |
DE10120619A1 (de) * | 2001-04-26 | 2002-10-31 | Merck Patent Gmbh | 2-(5-(4-Fluorphenyl)-3-pyridylmethylaminomethyl-chroman |
EP1411926B1 (en) * | 2001-08-01 | 2005-06-01 | MERCK PATENT GmbH | Integrin inhibitors for the treatment of eye diseases |
US6700001B2 (en) * | 2001-10-05 | 2004-03-02 | Wyeth | Process for stereoselective synthesis of 2-hydroxymethyl chromans |
BR0213030A (pt) * | 2001-10-05 | 2004-10-05 | Wyeth Corp | Processo estereoespecìfico para a sìntese de derivados de 2-il cromano |
EP1445324A4 (en) * | 2001-11-09 | 2005-02-16 | Kaneka Corp | PROCESS FOR PRODUCING OPTICALLY ACTIVE CHROMAN DERIVATIVE AND INTERMEDIATE PRODUCT |
US7196108B2 (en) * | 2002-03-08 | 2007-03-27 | Incyte San Diego Inc. | Bicyclic heterocycles for the treatment of diabetes and other diseases |
US20040097433A1 (en) | 2002-11-15 | 2004-05-20 | Sekhar Boddupalli | Chroman derivatives for the reduction of inflammation symptoms |
WO2005032544A1 (en) | 2003-09-19 | 2005-04-14 | Galileo Pharmaceuticals, Inc. | Treatment of mitochondrial diseases |
DE10348257A1 (de) | 2003-10-16 | 2005-05-25 | Merck Patent Gmbh | Verfahren zur Herstellung von enantiomereneinen in 2-Position substituierten Chromanderivaten |
US20050261347A1 (en) * | 2003-10-24 | 2005-11-24 | Wyeth | Dihydrobenzofuranyl alkanamine derivatives and methods for using same |
US7728155B2 (en) * | 2003-10-24 | 2010-06-01 | Wyeth Llc | Dihydrobenzofuranyl alkanamines and methods for using same as cns agents |
DE102004011265A1 (de) | 2004-03-09 | 2005-09-29 | Lutz F. Prof. Dr. Tietze | Synthese von Vitamin E |
GT200500296A (es) * | 2004-10-21 | 2006-10-02 | Sintesis asimetrica de derivados del dehidrobenzofurano | |
GT200500297A (es) * | 2004-10-21 | 2006-10-27 | Sintesis asimetrica de dehidrobenzofuranos sustituidos | |
KR101250824B1 (ko) | 2004-11-24 | 2013-04-05 | 아보트 러보러터리즈 | 바닐로이드 수용체 아형 1(vr1) 수용체를 억제하는크로마닐우레아 화합물 및 이의 용도 |
EP1871754A1 (en) * | 2005-04-22 | 2008-01-02 | Wyeth a Corporation of the State of Delaware | Dihydrobenzofuran derivatives and uses thereof |
CA2605587A1 (en) * | 2005-04-22 | 2006-11-02 | Wyeth | Chromane and chromene derivatives and uses thereof |
BRPI0610509A2 (pt) * | 2005-04-22 | 2010-06-29 | Wyeth Corp | tratamento de dependência a drogas |
BRPI0610028A2 (pt) * | 2005-04-22 | 2010-05-18 | Wyeth Corp | combinações terapêuticas para o tratamento ou a prevenção de distúrbios psicóticos |
WO2006116151A1 (en) * | 2005-04-22 | 2006-11-02 | Wyeth | Benzofuranyl alkanamine derivatives and uses thereof as 5-ht2c agonists |
JP2008538578A (ja) * | 2005-04-22 | 2008-10-30 | ワイス | 疼痛の治療 |
CN101203216A (zh) * | 2005-04-22 | 2008-06-18 | 惠氏公司 | 二氢苯并呋喃衍生物及其用途 |
EP1871355A1 (en) * | 2005-04-22 | 2008-01-02 | Wyeth | New therapeutic combianations for the treatment or prevention of depression |
CA2603900A1 (en) * | 2005-04-22 | 2006-11-02 | Wyeth | Crystal forms of {[(2r)-7-(2,6-dichlorophenyl)-5-fluoro-2,3-dihydro-1-benzofuran-2-yl]methyl}amine hydrochloride |
BRPI0610046A2 (pt) * | 2005-04-22 | 2010-05-25 | Wyeth Corp | derivados de benzodioxano e benzodioxolano e usos destes |
CN101203217A (zh) * | 2005-04-24 | 2008-06-18 | 惠氏公司 | 调节膀胱功能的方法 |
-
2006
- 2006-04-21 CA CA002605587A patent/CA2605587A1/en not_active Abandoned
- 2006-04-21 AR ARP060101590A patent/AR056320A1/es unknown
- 2006-04-21 US US11/409,467 patent/US7365095B2/en not_active Expired - Fee Related
- 2006-04-21 RU RU2007139541/04A patent/RU2007139541A/ru unknown
- 2006-04-21 EP EP06758490A patent/EP1874756A1/en not_active Withdrawn
- 2006-04-21 WO PCT/US2006/015208 patent/WO2006116165A1/en active Application Filing
- 2006-04-21 GT GT200600166A patent/GT200600166A/es unknown
- 2006-04-21 AU AU2006239937A patent/AU2006239937A1/en not_active Abandoned
- 2006-04-21 CN CNA2006800222674A patent/CN101203505A/zh active Pending
- 2006-04-21 TW TW095114313A patent/TW200716595A/zh unknown
- 2006-04-21 MX MX2007013163A patent/MX2007013163A/es unknown
- 2006-04-21 PE PE2006000415A patent/PE20061297A1/es not_active Application Discontinuation
- 2006-04-21 BR BRPI0610027-9A patent/BRPI0610027A2/pt not_active Application Discontinuation
- 2006-04-21 JP JP2008507952A patent/JP2008538576A/ja active Pending
- 2006-04-21 KR KR1020077027247A patent/KR20080008378A/ko not_active Application Discontinuation
-
2007
- 2007-10-19 ZA ZA200709052A patent/ZA200709052B/xx unknown
- 2007-10-22 IL IL186837A patent/IL186837A0/en unknown
- 2007-10-22 CO CO07110959A patent/CO6321153A2/es not_active Application Discontinuation
- 2007-11-06 NO NO20075641A patent/NO20075641L/no not_active Application Discontinuation
-
2008
- 2008-03-19 US US12/051,368 patent/US20080182891A1/en not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003029238A1 (en) * | 2001-10-04 | 2003-04-10 | Wyeth | Chroman derivatives as 5-hydroxytryptamine-6 ligands |
WO2003029239A1 (en) * | 2001-10-04 | 2003-04-10 | Wyeth | Chroman and benzofuran derivatives as 5-hydroxytryptamine-6 ligands |
WO2003031439A1 (en) * | 2001-10-05 | 2003-04-17 | Wyeth | Antidepressant chroman and chromene derivatives of 3-(1,2,3,6-tetrahydro-4-pyridinyl)-1h-indole |
WO2005044812A1 (en) * | 2003-10-24 | 2005-05-19 | Wyeth A Corporation Of The State Of Delaware | Dihydrobenzofuranyl alkanamine derivatives as 5ht2c agonists |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007123941A3 (en) * | 2006-04-18 | 2008-01-31 | Wyeth Corp | Chromane and chromene derivatives and uses thereof |
WO2007123941A2 (en) * | 2006-04-18 | 2007-11-01 | Wyeth | Chromane and chromene derivatives and uses thereof |
EP2727585A1 (en) | 2006-05-16 | 2014-05-07 | Takeda Pharmaceutical Company Limited | In-vivo screening method |
WO2007132841A1 (ja) | 2006-05-16 | 2007-11-22 | Takeda Pharmaceutical Company Limited | 縮合複素環化合物およびその用途 |
EP2742936A1 (en) | 2006-05-16 | 2014-06-18 | Takeda Pharmaceutical Company Limited | Fused heterocyclic compound and use thereof |
WO2008052087A1 (en) * | 2006-10-24 | 2008-05-02 | Wyeth | Chromane derivatives and uses thereof |
WO2008052088A1 (en) * | 2006-10-25 | 2008-05-02 | Wyeth | Chromane derivatives, synthesis thereof, and intermediates thereto |
WO2009063992A1 (ja) | 2007-11-15 | 2009-05-22 | Takeda Pharmaceutical Company Limited | 縮合ピリジン誘導体およびその用途 |
EP2789338A2 (en) | 2007-11-15 | 2014-10-15 | Takeda Pharmaceutical Company Limited | Condensed pyridine derivate and use thereof |
US8914112B2 (en) | 2008-01-23 | 2014-12-16 | Boston Scienctific Neuromodulation Corporation | Methods and systems of treating pancreatitis pain caused by sphincter of Oddi dysfunction |
US8676322B2 (en) | 2008-01-30 | 2014-03-18 | Boston Scientific Neuromodulation Corporation | Methods and systems of treating pancreatitis pain |
WO2011071136A1 (ja) | 2009-12-11 | 2011-06-16 | アステラス製薬株式会社 | 線維筋痛症治療剤 |
US9334212B2 (en) | 2010-12-21 | 2016-05-10 | Colgate-Palmolive Company | Compounds and compositions |
CN105392786A (zh) * | 2013-06-21 | 2016-03-09 | 济州大学校产学协力团 | 新型类黄酮及其用途 |
CN105392786B (zh) * | 2013-06-21 | 2018-02-16 | 济州大学校产学协力团 | 类黄酮及其用途 |
WO2015066344A1 (en) | 2013-11-01 | 2015-05-07 | Arena Pharmaceuticals, Inc. | 5-ht2c receptor agonists and compositions and methods of use |
WO2019131902A1 (ja) | 2017-12-27 | 2019-07-04 | 武田薬品工業株式会社 | 腹圧性尿失禁および便失禁の治療薬 |
Also Published As
Publication number | Publication date |
---|---|
JP2008538576A (ja) | 2008-10-30 |
IL186837A0 (en) | 2008-02-09 |
MX2007013163A (es) | 2008-01-21 |
US20060258714A1 (en) | 2006-11-16 |
EP1874756A1 (en) | 2008-01-09 |
CA2605587A1 (en) | 2006-11-02 |
KR20080008378A (ko) | 2008-01-23 |
ZA200709052B (en) | 2009-08-26 |
CN101203505A (zh) | 2008-06-18 |
PE20061297A1 (es) | 2006-12-24 |
GT200600166A (es) | 2007-03-14 |
AU2006239937A1 (en) | 2006-11-02 |
TW200716595A (en) | 2007-05-01 |
BRPI0610027A2 (pt) | 2010-05-18 |
CO6321153A2 (es) | 2011-09-20 |
US7365095B2 (en) | 2008-04-29 |
RU2007139541A (ru) | 2009-05-27 |
NO20075641L (no) | 2007-11-20 |
AR056320A1 (es) | 2007-10-03 |
US20080182891A1 (en) | 2008-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7365095B2 (en) | Chromane and chromene derivatives and uses thereof | |
US7368477B2 (en) | Benzofuranyl alkanamine derivatives and uses thereof | |
WO2006116158A1 (en) | Benzodioxane and benzodioxolane derivatives and uses thereof | |
EP1871356A1 (en) | Dihydrobenzofuran derivatives and uses thereof | |
US7402687B2 (en) | Dihydrobenzofuran derivatives and uses thereof | |
WO2008052086A1 (en) | Benzodioxane derivatives and uses thereof | |
JP2007509174A (ja) | 5ht2cアゴニストとしてのジヒドロベンゾフラニルアルカンアミン誘導体 | |
US20100035871A1 (en) | Benzoxazine derivatives and uses thereof | |
US20100160411A1 (en) | Benzoxathiine and benzoxathiole derivatives and uses thereof | |
WO2008052087A1 (en) | Chromane derivatives and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200680022267.4 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2006758490 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 3744/KOLNP/2007 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006239937 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 562454 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: CR2007-009451 Country of ref document: CR |
|
ENP | Entry into the national phase |
Ref document number: 2605587 Country of ref document: CA Ref document number: 2008507952 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 186837 Country of ref document: IL Ref document number: MX/a/2007/013163 Country of ref document: MX Ref document number: 12007502342 Country of ref document: PH Ref document number: 07110959 Country of ref document: CO |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2006239937 Country of ref document: AU Date of ref document: 20060421 Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007139541 Country of ref document: RU Ref document number: 1200702483 Country of ref document: VN Ref document number: 1020077027247 Country of ref document: KR |
|
ENP | Entry into the national phase |
Ref document number: PI0610027 Country of ref document: BR Kind code of ref document: A2 |